Latham & Watkins advised CyberArk on the transaction, and Kirkland & Ellis advised Thoma Bravo and its portfolio company Venafi. CyberArk (NASDAQ: CYBR), global leader in...
CyberArk’s $1.54 Billion Acquisition of Venafi
SLB’s Acquisition of ChampionX
Latham & Watkins represented SLB, while Weil, Gotshal & Manges represented ChampionX Corporation in the transaction. SLB (NYSE: SLB) has announced a definitive agreement to acquire...
Veralto Corporation’s $2.1 Billion Senior Notes Offering and €500 Million Senior Notes Offering
Wilmer Cutler advised Veralto, and Latham advised the initial purchasers on the offerings. On September 11, 2023, Veralto Corporation, a subsidiary of Danaher Corporation, agreed to...
US Foods Holding Corp’s Secondary Public Offering of Common Stock
Latham & Watkins’ capital markets team represents the underwriter in the offering by the leading foodservice distributor. US Foods Holding Corp. has announced the pricing of a...
Coinbase’s Acquisition of One River Digital Asset Management
Latham & Watkins represented Coinbase in the transaction. Coinbase announced that it has acquired One River Digital Asset Management (ORDAM). ORDAM will transition to become Coinbase Asset...
TPG’s $150 Million Investment in Palmetto
Latham & Watkins served as legal counsel to TPG. Palmetto announced it has raised $150 million to continue spurring the adoption of clean energy and access...
Ritchie Bros.’s $1.350 Billion Senior Notes Offering
Skadden and Dorsey & Whitney advised Ritchie Bros. Holdings Inc., McCarthy Tétrault advised Ritchie Bros. Auctioneers Incorporated, and Latham & Watkins advised the initial purchasers. Ritchie...
Indivior’s $145 Million Acquisition of Opiant Pharmaceuticals
Covington & Burling LLP advised Indivior, while Latham & Watkins LLP represented Opiant in the transaction. Opiant Pharmaceuticals Inc. (NASDAQ: OPNT) has entered into a definitive...